Unknown

Dataset Information

0

Targeted p21WAF1/CIP1 activation by RNAa inhibits hepatocellular carcinoma cells.


ABSTRACT: RNA activation (RNAa) is a mechanism of gene activation triggered by promoter-targeted small double-stranded RNA (dsRNA), also known as small activating RNA (saRNA). p21(WAF1/CIP1) (p21) is a putative tumor suppressor gene due to its role as a key negative regulator of the cell cycle and cell proliferation. It is frequently downregulated in cancer including hepatocellular carcinoma (HCC), but is rarely mutated or deleted, making it an ideal target for RNAa-based overexpression to restore its tumor suppressor function. In the present study, we investigated the antigrowth effects of p21 RNAa in HCC cells. Transfection of a p21 saRNA (dsP21-322) into HepG2 and Hep3B cells significantly induced the expression of p21 at both the mRNA and protein levels, and inhibited cell proliferation and survival. Further analysis of dsP21-322 transfected cells revealed that dsP21-322 arrested the cell cycle at the G(0)/G(1) phase in HepG2 cells but at G(2)/M phase in Hep3B cells which lack functional p53 and Rb genes, and induced both early and late stage apoptosis by activating caspase 3 in both cell lines. These results demonstrated that RNAa of p21 has in vitro antigrowth effects on HCC cells via impeding cell cycle progression and inducing apoptotic cell death. This study suggests that targeted activation of p21 by RNAa may be explored as a novel therapy for the treatment of HCC.

SUBMITTER: Kosaka M 

PROVIDER: S-EPMC3464408 | biostudies-literature | 2012 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Targeted p21WAF1/CIP1 activation by RNAa inhibits hepatocellular carcinoma cells.

Kosaka Mika M   Kang Moo Rim MR   Yang Glen G   Li Long-Cheng LC  

Nucleic acid therapeutics 20120821 5


RNA activation (RNAa) is a mechanism of gene activation triggered by promoter-targeted small double-stranded RNA (dsRNA), also known as small activating RNA (saRNA). p21(WAF1/CIP1) (p21) is a putative tumor suppressor gene due to its role as a key negative regulator of the cell cycle and cell proliferation. It is frequently downregulated in cancer including hepatocellular carcinoma (HCC), but is rarely mutated or deleted, making it an ideal target for RNAa-based overexpression to restore its tum  ...[more]

Similar Datasets

| S-EPMC3912217 | biostudies-literature
2020-03-28 | GSE110524 | GEO
| S-EPMC2995802 | biostudies-other
| S-EPMC3058037 | biostudies-literature
| S-EPMC6536968 | biostudies-literature
| S-EPMC5501671 | biostudies-literature
| S-EPMC3479215 | biostudies-literature
| S-EPMC5554444 | biostudies-literature
| S-EPMC7591575 | biostudies-literature
| S-EPMC5105918 | biostudies-literature